• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多次复发事件的预测:膀胱癌中扩展Cox模型的比较

Prediction of Multiple Recurrent Events: A Comparison of Extended Cox Models in Bladder Cancer.

作者信息

Smedinga Hilde, Steyerberg Ewout W, Beukers Willemien, van Klaveren David, Zwarthoff Ellen C, Vergouwe Yvonne

出版信息

Am J Epidemiol. 2017 Sep 1;186(5):612-623. doi: 10.1093/aje/kwx133.

DOI:10.1093/aje/kwx133
PMID:28525539
Abstract

Recurrence of bladder cancer can occur repeatedly in the same patient after treatment of the primary tumor. Models predicting the risk of a next recurrence may inform individualized decision-making on surveillance frequency. We aimed to assess the usefulness of extensions of the Cox proportional hazards model for repeated events in this context. We analyzed 531 Dutch patients with bladder cancer (1990-2012) with information on 7 prespecified predictors at the time of diagnosis of the primary and recurrent tumors. We considered 3 aspects of model variants: how to model time to the repeated events (calendar time, gap time, elapsed time); the number of preceding events (predictor, stratum variable); and the within-subject correlation (ignored in a simple Cox model, robust standard errors in a variance-correction model, random effect in a frailty model). First to fourth recurrences of bladder cancer occurred in 313, 174, 103, and 66 patients, respectively, with median calendar follow-up times of 1.1, 2.5, 3.8, and 4.5 years, respectively. We focused on gap time in the detailed analyses, allowing for clinically meaningful predictions. Variance-correction models may be useful if predictor selection is part of the model development. Frailty models may be useful when within-subject correlation is strong.

摘要

原发性肿瘤治疗后,膀胱癌复发可在同一患者中反复发生。预测下一次复发风险的模型可为监测频率的个体化决策提供依据。我们旨在评估在这种情况下Cox比例风险模型扩展用于重复事件的有效性。我们分析了531例荷兰膀胱癌患者(1990 - 2012年),这些患者在原发性肿瘤和复发性肿瘤诊断时具有7个预先指定预测因素的信息。我们考虑了模型变体的3个方面:如何对重复事件的时间进行建模(日历时间、间隔时间、经过时间);先前事件的数量(预测因素、分层变量);以及个体内相关性(简单Cox模型中忽略,方差校正模型中使用稳健标准误,脆弱模型中使用随机效应)。膀胱癌的首次至第四次复发分别发生在313、174、103和66例患者中,日历随访时间中位数分别为1.1、2.5、3.8和4.5年。在详细分析中,我们重点关注间隔时间,以便进行具有临床意义的预测。如果预测因素选择是模型开发的一部分,方差校正模型可能有用。当个体内相关性较强时,脆弱模型可能有用。

相似文献

1
Prediction of Multiple Recurrent Events: A Comparison of Extended Cox Models in Bladder Cancer.多次复发事件的预测:膀胱癌中扩展Cox模型的比较
Am J Epidemiol. 2017 Sep 1;186(5):612-623. doi: 10.1093/aje/kwx133.
2
Risk estimation of multiple recurrence and progression of non muscle invasive bladder carcinoma using new mathematical models.使用新的数学模型对非肌层浸润性膀胱癌的多次复发和进展进行风险评估。
Actas Urol Esp. 2014 Dec;38(10):647-54. doi: 10.1016/j.acuro.2014.04.007. Epub 2014 Jun 11.
3
EORTC Risk Model to Predict Progression in Patients With Non-Muscle-Invasive Bladder Cancer: Is It Safe to Use in Clinical Practice?预测非肌层浸润性膀胱癌患者病情进展的欧洲癌症研究与治疗组织(EORTC)风险模型:在临床实践中使用是否安全?
Clin Genitourin Cancer. 2016 Apr;14(2):176-82. doi: 10.1016/j.clgc.2015.09.005. Epub 2015 Sep 25.
4
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.在根治性膀胱切除术中,淋巴结阴性的患者中,淋巴管浸润与总生存期、特定病因生存期以及局部和远处复发独立相关。
J Clin Oncol. 2005 Sep 20;23(27):6533-9. doi: 10.1200/JCO.2005.05.516. Epub 2005 Aug 22.
5
Urine tenascin‑C is an independent risk factor for bladder cancer patients.尿 tenascin-C 是膀胱癌患者的独立危险因素。
Mol Med Rep. 2014 Mar;9(3):961-6. doi: 10.3892/mmr.2013.1873. Epub 2013 Dec 18.
6
Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.根治性肾输尿管切除术后上尿路尿路上皮癌膀胱复发的风险分层
BJU Int. 2015 May;115(5):705-12. doi: 10.1111/bju.12707. Epub 2015 Jan 21.
7
Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long-term follow-up experience at a single institute.预测原发性T1期高级别膀胱癌预后的危险因素探索及西班牙肿瘤治疗泌尿外科学会评分模型的验证:单机构长期随访经验
Int J Urol. 2015 Jun;22(6):541-7. doi: 10.1111/iju.12749. Epub 2015 Apr 8.
8
Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.根治性膀胱切除术术后复发和癌症特异性生存的分子标志物预测的前瞻性评估。
Eur Urol. 2013 Sep;64(3):465-71. doi: 10.1016/j.eururo.2013.03.043. Epub 2013 Apr 3.
9
Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.非肌肉浸润性膀胱癌患者的复发与进展:包括多色荧光原位杂交分子分级的预后模型
Int J Urol. 2014 Oct;21(10):968-72. doi: 10.1111/iju.12509. Epub 2014 Jun 19.
10
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.非肌层浸润性膀胱肿瘤史对上尿路尿路上皮癌患者的预后意义。
Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004. Epub 2012 Apr 21.

引用本文的文献

1
Systematic review of methods used in prediction models with recurrent event data.对具有复发事件数据的预测模型中使用的方法进行系统评价。
Diagn Progn Res. 2024 Aug 6;8(1):13. doi: 10.1186/s41512-024-00173-5.
2
The Influence of Dietary Isothiocyanates on the Effectiveness of Mitomycin C and Bacillus Calmette-Guérin in Treating Nonmuscle-Invasive Bladder Cancer.饮食中的异硫氰酸盐对丝裂霉素C和卡介苗治疗非肌层浸润性膀胱癌疗效的影响
J Urol. 2024 Sep;212(3):420-430. doi: 10.1097/JU.0000000000004070. Epub 2024 Jun 7.
3
Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort.
中危非肌层浸润性膀胱癌多次复发的自然史:来自前瞻性队列研究的经验。
Urology. 2023 Mar;173:134-141. doi: 10.1016/j.urology.2022.12.009. Epub 2022 Dec 24.
4
A Dynamic Risk Model for Multitype Recurrent Events.多类型复发事件的动态风险模型。
Am J Epidemiol. 2023 Apr 6;192(4):621-631. doi: 10.1093/aje/kwac213.
5
Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method.使用口服5-氨基酮戊酸的光动力诊断辅助经尿道切除术降低非肌层浸润性膀胱癌反复复发的风险:基于人时法的累积发病率分析
Diagnostics (Basel). 2021 Jan 28;11(2):185. doi: 10.3390/diagnostics11020185.
6
Cancer in General Responders Participating in World Trade Center Health Programs, 2003-2013.2003年至2013年参与世界贸易中心健康项目的一般应答者中的癌症情况
JNCI Cancer Spectr. 2019 Nov 6;4(1):pkz090. doi: 10.1093/jncics/pkz090. eCollection 2020 Feb.